Du, K., Du, K., Kang, N., Kang, N., Lin, Y., Lin, Y., . . . Hu, H. (2025). Senescence-associated signature based on immunotherapy response sequencing reveals PPIL3 as target for bladder cancer treatment and prognosis prediction. Frontiers Media S.A.
Chicago Style (17th ed.) CitationDu, Kaixuan, et al. Senescence-associated Signature Based on Immunotherapy Response Sequencing Reveals PPIL3 as Target for Bladder Cancer Treatment and Prognosis Prediction. Frontiers Media S.A, 2025.
MLA (9th ed.) CitationDu, Kaixuan, et al. Senescence-associated Signature Based on Immunotherapy Response Sequencing Reveals PPIL3 as Target for Bladder Cancer Treatment and Prognosis Prediction. Frontiers Media S.A, 2025.
Warning: These citations may not always be 100% accurate.